文献速递心力衰竭与心肌病

西北欧慢性心衰门诊患者的流行病学与长期结局

Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe.
PubMed 文献 · Heart · 2019-02-21

中位随访66个月期间51.4%患者死亡,校正多变量后生存与LVEF分类无关,但第二时期死亡率显著低于第一时期(HR 0.81,95%CI 0.72-0.91,p<0.001)。

要点

  • 稳定慢性心衰门诊患者中HFrEF占68.7%、HFmrEF占20.2%、HFpEF占11.1%。
  • 中位随访66个月期间51.4%患者死亡,但校正多变量后生存与LVEF分类无关。
  • 第二时期(2006-2015)死亡率较第一时期(1995-2005)显著降低(HR 0.81)。

核心结论

  • 按LVEF分层的慢性心衰门诊患者代表不同表型,但校正广泛协变量后长期生存与LVEF分类无关。
  • 过去二十年间无论心衰类型如何,患者结局均显著改善。

研究设计与样本

  • 患者按基线LVEF分类,并按入组时间分为1995-2005年(4617例,44.8%)和2006-2015年(5695例,55.2%)两个时期。
  • 采用单变量和多变量Cox回归分析死亡预测因素。

主要发现

  • 中位随访66(33-105)个月期间5297例(51.4%)死亡。
  • 多变量分析显示生存与LVEF分类无关(p>0.05)。
  • 第二时期死亡率低于第一时期(HR 0.81,95% CI 0.72-0.91,p<0.001)。
  • 无论心衰类别,全因死亡的显著预测因素包括年龄增加、NYHA功能分级、NT-proBNP和袢利尿剂使用。

临床怎么用

  • 门诊慢性心衰患者评估应关注年龄、NYHA分级、NT-proBNP和袢利尿剂使用等死亡预测因素,而非仅依据LVEF分类判断预后。
  • 长期随访中应认识到近二十年心衰患者生存已显著改善,治疗策略需结合入组时期背景解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the epidemiology, long-term outcomes and temporal trends in mortality in ambulatory patients with chronic heart failure (HF) with reduced (HFrEF), mid-range (HFmrEF) or preserved ejection fraction (HFpEF) from three European countries. METHODS: We identified 10 312 patients from the Norwegian HF Registry and the HF registries of the universities of Heidelberg, Germany, and Hull, UK. Patients were classified according to baseline left ventricular ejection fraction (LVEF) and time of enrolment (period 1: 1995-2005 vs period 2: 2006-2015). Predictors of mortality were analysed by use of univariable and multivariable Cox regression analyses. RESULTS: Among 10 312 patients with stable HF, 7080 (68.7%), 2086 (20.2%) and 1146 (11.1%) were classified as having HFrEF, HFmrEF or HFpEF, respectively. A total of 4617 (44.8%) patients were included in period 1, and 5695 (55.2%) patients were included in period 2. Baseline characteristics significantly differed with respect to type of HF and time of enrolment. During a median follow-up of 66 (33-105) months, 5297 patients (51.4%) died. In multivariable analyses, survival was independent of LVEF category (p>0.05), while mortality was lower in period 2 as compared with period 1 (HR 0.81, 95% CI 0.72 to 0.91, p<0.001). Significant predictors of all-cause mortality regardless of HF category were increasing age, New York Heart Association functional class, N-terminal pro-brain natriuretic peptide and use of loop diuretics. CONCLUSION: Ambulatory patients with HF stratified by LVEF represent different phenotypes. However, after adjusting for a wide range of covariates, long-term survival is independent of LVEF category. Outcome significantly improved during the last two decades irrespective from type of HF.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Fröhlich H, Rosenfeld N, Täger T, et al. Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe. Heart. 2019. PMID: 30792238. doi:10.1136/heartjnl-2018-314256

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。